Physician profile
Jeffrey Csiszar
NPI 1902807829
$2,134.71
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $795 · 2020: $193 · 2021: $134 · 2022: $334 · 2023: $276 · 2024: $403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $403 · Food and Beverage: $276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $403.18 |
| Food and Beverage | $276.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $695.23 | 2019-2023 | Xtandi |
| Olympus America INC. | $421.45 | 2023-2024 | Itind System |
| Abbvie INC. | $194.31 | 2019-2022 | |
| Antares Pharma, INC. | $124.99 | 2023 | Xyosted, Tlando |
| Intuitive Surgical, INC. | $86.51 | 2022 | |
| Janssen Biotech, INC. | $84.64 | 2019-2023 | Erleada |
| Ferring Pharmaceuticals INC. | $77.05 | 2019-2020 | |
| Coloplast Corp | $59.13 | 2022-2023 | Speedicath, Vortek Hydro, Altis |
| Boston Scientific Corporation | $58.64 | 2019-2022 | |
| Pfizer INC. | $52.57 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $47.05 | 2021-2022 | |
| Travere Therapeutics, INC. | $40.66 | 2019-2020 | |
| Myovant Sciences INC. | $40.05 | 2022 | |
| Sun Pharmaceutical Industries INC. | $40.02 | 2019 | |
| Urovant Sciences INC | $34.48 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $26.42 | 2019 | |
| Novartis Pharmaceuticals Corporation | $24.20 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.66 | 2020 | |
| Endo Pharmaceuticals INC. | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Csiszar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.